{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:22:00Z","timestamp":1767705720139,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1006\/bcmd.2001.0428","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T10:51:07Z","timestamp":1032173467000},"page":"610-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Flavopiridol Induces Apoptosis and Caspase-3 Activation of a Newly Characterized Burkitt's Lymphoma Cell Line Containing Mutant P53 Genes"],"prefix":"10.1006","volume":"27","author":[{"given":"Aaron P.","family":"Rapoport","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Simons-Evelyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rochel","family":"Sidell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Luhowskyj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Obrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M.","family":"Hinkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon","family":"Nahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille N.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/bcmd.2001.0428_RF1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","article-title":"The pathogenesis of Burkitt's lymphoma","volume":"55","author":"Magrath","year":"1990","journal-title":"Adv. Cancer Res."},{"key":"10.1006\/bcmd.2001.0428_RF2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood.V80.1.8.8","article-title":"Acquired immunodeficiency syndrome-related lymphoma","volume":"80","author":"Levine","year":"1992","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ijc.2910130605","article-title":"Relationship between Epstein\u2013Barr virus DNA and the EBV determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies","volume":"13","author":"Lindahl","year":"1974","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2001.0428_RF4","first-page":"835","article-title":"Establishment of lymphomatous cell lines from bone marrow samples from patients with Burkitt's lymphoma","volume":"73","author":"Philip","year":"1984","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1006\/bcmd.2001.0428_RF5","first-page":"841","article-title":"Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin","volume":"73","author":"Favrot","year":"1984","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1006\/bcmd.2001.0428_RF6","first-page":"465","article-title":"Characterization of lymphoma-derived cell lines: Comparison of cell lines positive and negative for Epstein\u2013Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics","volume":"64","author":"Magrath","year":"1980","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1006\/bcmd.2001.0428_RF7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.2910370307","article-title":"Epstein\u2013Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma","volume":"37","author":"Rowe","year":"1986","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2001.0428_RF8","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","article-title":"Differences in B cell growth phenotype reflect novel patterns of Epstein\u2013Barr virus latent gene expression in Burkitt's lymphoma","volume":"6","author":"Rowe","year":"1987","journal-title":"EMBO J."},{"key":"10.1006\/bcmd.2001.0428_RF9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ijc.2910170108","article-title":"Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas","volume":"17","author":"Zech","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2001.0428_RF10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1126\/science.6401867","article-title":"Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas","volume":"219","author":"Dalla-Favera","year":"1983","journal-title":"Science"},{"key":"10.1006\/bcmd.2001.0428_RF11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/304135a0","article-title":"Translocation joins c-myc and immunoglobulin \u03b31 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene","volume":"304","author":"Hamlyn","year":"1983","journal-title":"Nature"},{"key":"10.1006\/bcmd.2001.0428_RF12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/307752a0","article-title":"A variant translocation places the \u03b3 immunoglobulin genes 3\u2032 to the c-myc oncogene in Burkitt's lymphoma","volume":"307","author":"Hollis","year":"1984","journal-title":"Nature"},{"key":"10.1006\/bcmd.2001.0428_RF13","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1073\/pnas.80.22.6922","article-title":"Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C\u03bb locus in Burkitt lymphoma cells","volume":"80","author":"Croce","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bcmd.2001.0428_RF14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/349612a0","article-title":"Activation of Epstein\u2013Barr virus latent genes protects human B cells from death by apoptosis","volume":"349","author":"Gregory","year":"1991","journal-title":"Nature"},{"key":"10.1006\/bcmd.2001.0428_RF15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.V80.2.459.459","article-title":"Expression of bcl-2 in Burkitt's lymphoma cell lines: Induction by latent Epstein\u2013Barr virus genes","volume":"80","author":"Finke","year":"1992","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ijc.2910510619","article-title":"Expression of Epstein\u2013Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line","volume":"51","author":"Cuomo","year":"1992","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2001.0428_RF17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1096\/fasebj.7.10.8344493","article-title":"Hemi- or homozygosity: A requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect","volume":"7","author":"Bhatia","year":"1993","journal-title":"FASEB J."},{"key":"10.1006\/bcmd.2001.0428_RF18","first-page":"7805","article-title":"Transactivation of the human p53 tumor suppressor gene by c-Myc\/Max contributes to elevated mutant p53 expression in some tumors","volume":"14","author":"Roy","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/bcmd.2001.0428_RF19","first-page":"4776","article-title":"Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines","volume":"53","author":"O'Connor","year":"1993","journal-title":"Cancer Res."},{"key":"10.1006\/bcmd.2001.0428_RF20","first-page":"2387","article-title":"Relationships between G1 arrest and stability of the p53 and p21Cip1\/Waf1 proteins following gamma-irradiation of human lymphoma cells","volume":"55","author":"Bae","year":"1995","journal-title":"Cancer Res."},{"key":"10.1006\/bcmd.2001.0428_RF21","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1002\/j.1460-2075.1995.tb00182.x","article-title":"DNA damage in human B cells can induce apoptosis, proceeding from G1\/S when p53 is transactivation competent and G2\/M when it is transactivation defective","volume":"14","author":"Allday","year":"1995","journal-title":"EMBO J."},{"key":"10.1006\/bcmd.2001.0428_RF22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood.V63.5.1102.1102","article-title":"An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults","volume":"63","author":"Magrath","year":"1984","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1200\/JCO.1985.3.5.627","article-title":"Curability of Burkitt's lymphoma with high-dose cyclophosphamide\u2013high-dose methotrexate therapy and intrathecal chemoprophylaxis","volume":"3","author":"Sullivan","year":"1985","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/bcmd.2001.0428_RF24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.1986.4.6.847","article-title":"Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types)","volume":"4","author":"Bernstein","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/bcmd.2001.0428_RF25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/bcmd.2001.0428_RF26","first-page":"5314","article-title":"Apoptosis induced in Burkitt's lymphoma cells via Gb3\/CD77, a glycolipid antigen","volume":"53","author":"Mangeney","year":"1993","journal-title":"Cancer Res."},{"key":"10.1006\/bcmd.2001.0428_RF27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ijc.2910360508","article-title":"Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells","volume":"36","author":"Murray","year":"1985","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2001.0428_RF28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ijc.2910480610","article-title":"Monoclonal antibodies against Gal\u03b11-4Gal\u03b21-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: Reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors","volume":"48","author":"Oosterwijk","year":"1991","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2001.0428_RF29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/excr.1994.1309","article-title":"Interferon-gamma (IFN-gamma) induces programmed cell death in differentiated human leukemic B cell lines","volume":"215","author":"Trubiani","year":"1994","journal-title":"Exp. Cell Res."},{"key":"10.1006\/bcmd.2001.0428_RF30","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/bbrc.1994.1479","article-title":"Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells","volume":"200","author":"Zhang","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/bcmd.2001.0428_RF31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.2910610313","article-title":"Effects of interferon-alpha on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines","volume":"61","author":"Milner","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2001.0428_RF32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/bbrc.1994.1036","article-title":"Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA","volume":"198","author":"Filippovich","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/bcmd.2001.0428_RF33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ijc.2910570321","article-title":"Regulation of cell survival in Burkitt lymphoma: Implications from studies of apoptosis following cold-shock treatment","volume":"57","author":"Gregory","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1006\/bcmd.2001.0428_RF34","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V87.3.1147.bloodjournal8731147","article-title":"Transforming growth factor-\u03b21 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines","volume":"87","author":"Macdonald","year":"1996","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood.V88.4.1375.bloodjournal8841375","article-title":"CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells","volume":"88","author":"Schattner","year":"1996","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF36","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1182\/blood.V86.11.4286.bloodjournal86114286","article-title":"Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors","volume":"86","author":"O'Connor","year":"1995","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02790449","article-title":"Synchronization of 9L rat brain tumor cells by centrifugal elutriation","volume":"2","author":"Keng","year":"1980","journal-title":"Cell Biophys."},{"key":"10.1006\/bcmd.2001.0428_RF38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0145-2126(88)90049-5","article-title":"Separation of spontaneously differentiating and cell cycle-specific populations of HL-60 cells","volume":"4","author":"Palis","year":"1988","journal-title":"Leukemia Res."},{"key":"10.1006\/bcmd.2001.0428_RF39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/36.3.3278057","article-title":"A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues","volume":"36","author":"Shi","year":"1988","journal-title":"J. Histochem. Cytochem."},{"key":"10.1006\/bcmd.2001.0428_RF40","first-page":"579","article-title":"Nonradioactive in situ hybridization using digoxigenin labeled oligonucleotides: Applications to musculoskeletal tissues","volume":"141","author":"Crabb","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1006\/bcmd.2001.0428_RF41","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199503163321104","article-title":"Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck","volume":"332","author":"Brennan","year":"1995","journal-title":"New Engl. J. Med."},{"key":"10.1006\/bcmd.2001.0428_RF42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V88.2.479.bloodjournal882479","article-title":"Granulocyte\u2013macrophage colony-stimulating factor receptor: Stage-specific expression and function on late B cells","volume":"88","author":"Till","year":"1996","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.iy.10.040192.001455","article-title":"Cytokine receptors and signal transduction","volume":"10","author":"Miyajima","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/bcmd.2001.0428_RF44","first-page":"65","article-title":"Shiga toxin: Biochemistry, genetics, mode of action, and role in pathogenesis","volume":"180","author":"O'Brien","year":"1992","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1006\/bcmd.2001.0428_RF45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jcp.1041500324","article-title":"Susceptibility to verotoxin as a function of the cell cycle","volume":"150","author":"Pudymaitis","year":"1992","journal-title":"J. Cell. Physiol."},{"key":"10.1006\/bcmd.2001.0428_RF46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.275.5298.343","article-title":"An information-intensive approach to the molecular pharmacology of cancer","volume":"275","author":"Weinstein","year":"1997","journal-title":"Science"},{"key":"10.1006\/bcmd.2001.0428_RF47","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.V88.5.1561.1561","article-title":"Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice","volume":"88","author":"Lacasse","year":"1996","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0003-9861(91)90064-P","article-title":"Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: Differential basis of phenotype","volume":"286","author":"Pudymaitis","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1006\/bcmd.2001.0428_RF49","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1074\/jbc.275.9.6246","article-title":"Retroviral transfection of Madin\u2013Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 105- to 106-fold increased cell sensitivity to verocytotoxin","volume":"275","author":"Lala","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bcmd.2001.0428_RF50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1006\/bbrc.1994.1742","article-title":"Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275","volume":"201","author":"Losiewicz","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/bcmd.2001.0428_RF51","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/0006-2952(93)90590-S","article-title":"Alteration of the phosphorylation state of P34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells","volume":"46","author":"Worland","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/bcmd.2001.0428_RF52","first-page":"2973","article-title":"Flavopiridol induced G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells","volume":"56","author":"Carlson","year":"1996","journal-title":"Cancer Res."},{"key":"10.1006\/bcmd.2001.0428_RF53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0891-5849(94)90241-0","article-title":"Effects of \u03b3-linolenic acid, flavonoids, and vitamins on cytotoxicity and lipid peroxidation","volume":"16","author":"Ramanathan","year":"1994","journal-title":"Free Radical Biol. Med."},{"key":"10.1006\/bcmd.2001.0428_RF54","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/jnci\/84.22.1736","article-title":"Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275","volume":"84","author":"Kaur","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1006\/bcmd.2001.0428_RF55","first-page":"1143","article-title":"Flavopiridol (L868275:NSC 649890), a new kinase inhibitor for tumor therapy","volume":"9","author":"Sedlacek","year":"1996","journal-title":"Int. J. Oncol."},{"key":"10.1006\/bcmd.2001.0428_RF56","first-page":"4856","article-title":"Flavopiridol: A cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells","volume":"56","author":"Bible","year":"1996","journal-title":"Cancer Res."},{"key":"10.1006\/bcmd.2001.0428_RF57","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1182\/blood.V91.2.458","article-title":"Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol","volume":"91","author":"Parker","year":"1998","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF58","first-page":"2482","article-title":"Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts","volume":"91","author":"Arguello","year":"1998","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF59","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood.V92.10.3804","article-title":"Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53","volume":"92","author":"Byrd","year":"1998","journal-title":"Blood"},{"key":"10.1006\/bcmd.2001.0428_RF60","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1200\/JCO.1998.16.9.2986","article-title":"Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms","volume":"16","author":"Senderowicz","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1006\/bcmd.2001.0428_RF61","first-page":"3375","article-title":"Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: The importance of sequence of administration","volume":"57","author":"Kaufmann","year":"1997","journal-title":"Cancer Res."},{"key":"10.1006\/bcmd.2001.0428_RF62","first-page":"501","article-title":"The protein kinase C (PKC) inhibitors UCN-01 and flavopiridol (FLAVO) significantly enhance the cytotoxic effect of chemotherapy by promoting apoptosis in gastric and breast cancer cells","volume":"15","author":"Schwartz","year":"1996","journal-title":"Proc. ASCO"},{"key":"10.1006\/bcmd.2001.0428_RF63","first-page":"547a","article-title":"The enhancement of chemotherapy-induced apoptosis by flavopiridol (FLAVO) in gastric cancer cells is sequence-dependent","volume":"16","author":"Werner","year":"1997","journal-title":"Proc. ASCO"},{"key":"10.1006\/bcmd.2001.0428_RF64","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1517\/13543784.9.12.2903","article-title":"Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: Current status","volume":"12","author":"Kelland","year":"2000","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1006\/bcmd.2001.0428_RF65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/1097-4644(20010401)81:1<128::AID-JCB1029>3.0.CO;2-G","article-title":"Activation of the caspase cascade during Stx1-induced apoptosis in Burkitt's lymphoma cells","volume":"1","author":"Kiyokawa","year":"2001","journal-title":"J. Cell. Biochem"},{"key":"10.1006\/bcmd.2001.0428_RF66","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","article-title":"Cyclins and cancer II: Cyclin D and CDK inhibitors come of age","volume":"79","author":"Hunter","year":"1994","journal-title":"Cell"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979601904280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979601904280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:17:12Z","timestamp":1761049032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979601904280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S1079979601904280"],"URL":"https:\/\/doi.org\/10.1006\/bcmd.2001.0428","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flavopiridol Induces Apoptosis and Caspase-3 Activation of a Newly Characterized Burkitt's Lymphoma Cell Line Containing Mutant P53 Genes","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/bcmd.2001.0428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}